Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 4, 2014, Pages 793-800

  Iuchi, Toshihiko ^a   Hatano, Kazuo ^a   Kodama, Takashi ^a   Sakaida, Tsukasa ^a   Yokoi, Sana ^a   Kawasaki, Koichiro ^a   Hasegawa, Yuzo ^a   Hara, Ryusuke ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; DETERIORATION; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; TOXICITY;

FLUID ATTENUATED INVERSION RECOVERIES; METHODS AND MATERIALS; NEWLY DIAGNOSED GLIOBLASTOMA; PATIENT SURVIVALS; PERFORMANCE STATUS; PLANNING TARGET VOLUMES; PROGRESSION FREE SURVIVAL; RADIATION NECROSIS;

RADIOTHERAPY;

ANTICONVULSIVE AGENT; DEXAMETHASONE; METHIONINE C 11; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRAIN FOURTH VENTRICLE; BRAIN STEM; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CAUSE OF DEATH; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DETERIORATION; DISTANT FAILURE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KARNOFSKY PERFORMANCE STATUS; LATERAL BRAIN VENTRICLE; LIVER DYSFUNCTION; LONG TERM CARE; LYMPHOCYTOPENIA; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RADIOTHERAPY PLANNING SYSTEM; RASH; SUBVENTRICULAR ZONE; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR VOLUME; VERTEBRAL CANAL; VERY ELDERLY;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN; BRAIN NEOPLASMS; CAUSE OF DEATH; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECROSIS; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84896708232     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.12.011     Document Type: Article

References (31)

1. R. Stupp, M.E. Hegi, and W.P. Mason et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
2. J. Sherriff, J. Tamangani, and L. Senthil et al. Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide Br J Radiol 86 2013 20120414
3. M.E. Hegi, A.C. Diserens, and T. Gorlia et al. MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003
4. D.A. Lim, S. Cha, and M.C. Mayo et al. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype Neuro Oncol 9 2007 424 429
5. K. Nakagawa, Y. Aoki, and T. Fujimaki et al. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme Int J Radiat Oncol Biol Phys 40 1998 1141 1149
6. J.L. Chan, S.W. Lee, and B.A. Fraass et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy J Clin Oncol 20 2002 1635 1642
7. R. Graf, B. Hildebrandt, and W. Tilly et al. Dose-escalated conformal radiotherapy of glioblastomas: results of a retrospective comparison applying radiation doses of 60 and 70 Gy Onkologie 28 2005 325 330
8. J.M. Watkins, D.T. Marshall, and S. Patel et al. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas J Neurooncol 93 2009 343 348
9. C. Tsien, J. Moughan, and J.M. Michalski et al. Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03 Int J Radiat Oncol Biol Phys 73 2009 699 708
10. M. Hingorani, W.P. Colley, and S. Dixit et al. Hypofractionated radiotherapy for glioblastoma: Strategy for poor-risk patients or hope for the future? Br J Radiol 85 2012 e770 e781
11. J.Z. Wang, and X.A. Li Impact of tumor repopulation on radiotherapy planning Int J Radiat Oncol Biol Phys 61 2005 220 227
12. L. Hlatky, M. Olesiak, and P. Hahnfeldt Measurement of potential doubling time for human tumor xenografts using the cytokinesis-block method Cancer Res 56 1996 1660 1663
13. C.E. Furneaux, E.S. Marshall, and K. Yeoh et al. Cell cycle times of short-term cultures of brain cancers as predictors of survival Br J Cancer 99 2008 1678 1683
14. K. Sultanem, H. Patrocinio, and C. Lambert et al. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: Preliminary results of a prospective trial Int J Radiat Oncol Biol Phys 58 2004 247 252
15. N.S. Floyd, S.Y. Woo, and B.S. Teh et al. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme Int J Radiat Oncol Biol Phys 58 2004 721 726
16. T. Iuchi, K. Hatano, and Y. Narita et al. Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT Int J Radiat Oncol Biol Phys 64 2006 1317 1324
17. C. Chen, D. Damek, and L.E. Gaspar et al. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme Int J Radiat Oncol Biol Phys 81 2011 1066 1074
18. C.I. Tsien, D. Brown, and D. Normolle et al. Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma Clin Cancer Res 18 2012 273 279
19. I.J. Barani, S.H. Benedict, and P.S. Lin Neural stem cells: Implications for the conventional radiotherapy of central nervous system malignancies Int J Radiat Oncol Biol Phys 68 2007 324 333
20. S.C. Li, L.T. Vu, and H.W. Ho et al. Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall Cancer Cell Int 12 2012 41
21. P. Evers, P.P. Lee, and J. DeMarco et al. Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma BMC Cancer 10 2010 384
22. P. Lee, W. Eppinga, and F. Lagerwaard et al. Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: A pooled analysis Int J Radiat Oncol Biol Phys 86 2013 609 615
23. L. Chen, H. Guerrero-Cazares, and X. Ye et al. Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection Int J Radiat Oncol Biol Phys 86 2013 616 622
24. S. Bao, Q. Wu, and R.E. McLendon et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
25. G.T. Armstrong, N. Jain, and W. Liu et al. Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies Neuro Oncol 12 2010 1173 1186
26. R. Jalali, I. Mallick, and D. Dutta et al. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy Int J Radiat Oncol Biol Phys 77 2010 974 979
27. K.J. Redmond, E.M. Mahone, and S. Terezakis et al. Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: A prospective study Neuro Oncol 15 2013 360 369
28. M. Tripathi, R. Sharma, and R. Varshney et al. Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors Clin Nucl Med 37 2012 158 163
29. A.W. Glaudemans, R.H. Enting, and M.A. Heesters et al. Value of 11C-methionine PET in imaging brain tumours and metastases Eur J Nucl Med Mol Imaging 40 2013 615 635
30. Y. Terakawa, N. Tsuyuguchi, and Y. Iwai et al. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy J Nucl Med 49 2008 694 699
31. S. Okamoto, T. Shiga, and N. Hattori et al. Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions Ann Nucl Med 25 2011 213 220